@article{40291a64297a43df9a18a14b91e4beb8,
title = "Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer",
keywords = "CARCINOMA-CELL-LINE, SELECTIVE-INHIBITION, EZH2, GALLBLADDER, EXPRESSION, OVEREXPRESSION, PROLIFERATION, ESTABLISHMENT, PROGRESSION, METASTASIS",
author = "Dino Bekric and Daniel Neureiter and Celina Ablinger and Heidemarie Dobias and Marlena Beyreis and Markus Ritter and Martin Jakab and Johannes Bischof and Ulrich Koller and Tobias Kiesslich and Mayr, {Christian Reinhard}",
note = "Bekric, Dobias, Beyreis, Ritter, Jakab, Kiesslich, Mayr: Center of Physiology, Pathophysiology and Biophysics, Institute of Physiology and Pathophysiology, Paracelsus Medical University, 5020 Salzburg, Austria; Daniel Neureiter: Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (SALK), 5020 Salzburg, Austria; Johannes Bischof, Ulrich Koller: Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, Paracelsus Medical University/University Hospital Salzburg (SALK), 5020 Salzburg, Austria; Kiesslich, Mayr: Department of Internal Medicine I, Paracelsus Medical University/University Hospital Salzburg (SALK), 5020 Salzburg, Austria; Ritter: Gastein Research Institute, Paracelsus Medical University, 5020 Salzburg, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University, 5020 Salzburg, Austria; Ablinger: Institute of Pharmacy, Paracelsus Medical University, 5020 Salzburg, Austria",
year = "2023",
month = mar,
day = "2",
doi = "10.3390/cancers15051569",
language = "English",
volume = "15",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI",
number = "5",
}